Literature DB >> 30710745

Free versus total serum 25-hydroxyvitamin D in a murine model of colitis.

D P Larner1, C Jenkinson1, R F Chun2, C S J Westgate1, J S Adams2, M Hewison3.   

Abstract

Inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease have been linked to vitamin D-deficiency. Using a dextran sodium sulphate (DSS)-induced model of IBD we have shown previously that mice raised on vitamin D-deficient diets from weaning have lower serum 25-hydroxyvitamin D (25OHD) levels and develop more severe colitis compared to vitamin D-sufficient counterparts. We have also shown in vitro that immune responses to 25OHD may depend on 'free' rather than total serum concentrations of 25OHD. To investigate the possible effects of free versus total 25OHD on anti-inflammatory immune responses in vivo we have studied DSS-induced colitis in wild type C57BL/6 mice raised from weaning on diets containing vitamin D2 (D2) or vitamin D3 (D3) only (both 1000 IU/kg feed). 25OHD2 has lower binding affinity for the vitamin D binding protein than 25OHD3 which results in higher levels of free 25OHD2 relative to free 25OHD3 in mice raised on a D2-only diet. Total serum 25OHD concentrations, measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS), showed that D2 mice had significantly lower levels of 25OHD than D3 mice (6.85 ± 2.61 nmol/L vs. 49.16 ± 13.8 nmol/L for D2 and D3 respectively). Despite this, direct ELISA measurement showed no difference in free serum 25OHD levels between D2 and D3 mice (13.62 ± 2.26 pmol/L vs. 14.11 ± 2.24 pmol/L for D2 and D3 respectively). Analysis of DSS-induced colitis also showed no difference in weight loss or disease progression between D2 and D3 mice. These data indicate that despite D2-fed mice being vitamin D-deficient based on serum total 25OHD concentrations, these mice showed no evidence of increased inflammatory colitis disease relative to vitamin D-sufficient D3 mice. We therefore propose that free, rather than total serum 25OHD, may be a better marker of immune responses to vitamin D in vivo.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colitis; Free vitamin D; Inflammation; Mouse; Total vitamin D; Vitamin D; Vitamin D binding protein; Vitamin D2; Vitamin D3

Mesh:

Substances:

Year:  2019        PMID: 30710745      PMCID: PMC6502676          DOI: 10.1016/j.jsbmb.2019.01.015

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  43 in total

1.  Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men.

Authors:  P Srikanth; R F Chun; M Hewison; J S Adams; R Bouillon; D Vanderschueren; N Lane; P M Cawthon; T Dam; E Barrett-Connor; L B Daniels; J M Shikany; M L Stefanick; J A Cauley; E S Orwoll; C M Nielson
Journal:  Osteoporos Int       Date:  2016-02-23       Impact factor: 4.507

2.  Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein.

Authors:  F F Safadi; P Thornton; H Magiera; B W Hollis; M Gentile; J G Haddad; S A Liebhaber; N E Cooke
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

Review 3.  The free hormone hypothesis: a physiologically based mathematical model.

Authors:  C M Mendel
Journal:  Endocr Rev       Date:  1989-08       Impact factor: 19.871

Review 4.  Antibacterial effects of vitamin D.

Authors:  Martin Hewison
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

5.  An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3.

Authors:  A Nykjaer; D Dragun; D Walther; H Vorum; C Jacobsen; J Herz; F Melsen; E I Christensen; T E Willnow
Journal:  Cell       Date:  1999-02-19       Impact factor: 41.582

6.  Differences in mineral metabolism among nonhuman primates receiving diets with only vitamin D3 or only vitamin D2.

Authors:  S J Marx; G Jones; R S Weinstein; G P Chrousos; D M Renquist
Journal:  J Clin Endocrinol Metab       Date:  1989-12       Impact factor: 5.958

7.  Vitamin D status in children and young adults with inflammatory bowel disease.

Authors:  Helen M Pappa; Catherine M Gordon; Tracee M Saslowsky; Anna Zholudev; Brian Horr; Mei-Chiung Shih; Richard J Grand
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

8.  Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites.

Authors:  B W Hollis
Journal:  J Steroid Biochem       Date:  1984-07       Impact factor: 4.292

9.  Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.

Authors:  Juan Kong; Zhongyi Zhang; Mark W Musch; Gang Ning; Jun Sun; John Hart; Marc Bissonnette; Yan Chun Li
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-25       Impact factor: 4.052

10.  Displacement potency of vitamin D2 analogs in competitive protein-binding assays for 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D3, and 1,25-dihydroxyvitamin D3.

Authors:  G Jones; B Byrnes; F Palma; D Segev; Y Mazur
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958

View more
  2 in total

Review 1.  The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management.

Authors:  Jane Fletcher; Sheldon C Cooper; Subrata Ghosh; Martin Hewison
Journal:  Nutrients       Date:  2019-05-07       Impact factor: 5.717

2.  Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study.

Authors:  Emma A Hurst; Richard J Mellanby; Ian Handel; David M Griffith; Adriano G Rossi; Timothy S Walsh; Manu Shankar-Hari; Jake Dunning; Natalie Z Homer; Scott G Denham; Kerri Devine; Paul A Holloway; Shona C Moore; Ryan S Thwaites; Romit J Samanta; Charlotte Summers; Hayley E Hardwick; Wilna Oosthuyzen; Lance Turtle; Malcolm G Semple; Peter J M Openshaw; J Kenneth Baillie; Clark D Russell
Journal:  BMJ Open       Date:  2021-10-22       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.